@prefix fhir: . @prefix owl: . @prefix rdf: . @prefix rdfs: . @prefix xsd: . # - resource ------------------------------------------------------------------- a fhir:Group ; fhir:nodeRole fhir:treeRoot ; fhir:id [ fhir:v "236535"] ; # fhir:meta [ fhir:versionId [ fhir:v "77" ] ; fhir:lastUpdated [ fhir:v "2026-01-29T20:44:43.900Z"^^xsd:dateTime ] ; fhir:profile ( [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/exposure-group"^^xsd:anyURI ; fhir:l ] ) ] ; # fhir:language [ fhir:v "en"] ; # fhir:text [ fhir:status [ fhir:v "extensions" ] ; fhir:div [ fhir:v "

Generated Narrative: Group 236535

version: 77; Last updated: 2026-01-29 20:44:43+0000; Language: en

Profile: ExposureGroup

Artifact Author: Computable Publishing®: MAGIC-to-FEvIR Converter:

Artifact related artifact: No display for RelatedArtifact (type: part-of; resourceReference: ->display: string (PrimitiveType/Group.extension[1].value[x].resourceReference.display): element = string -> display=string[MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes])

CiteAs:

GLP-1 RA Group in at-risk Adults with type 2 diabetes with moderate CV risk [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236535. Revised 2026-01-29. Available at: https://fevir.net/resources/Group/236535. Computable resource at: https://fevir.net/resources/Group/236535#json.

\n

url: https://fevir.net/resources/Group/236535

identifier: FEvIR Object Identifier/236535, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-intervention-group-MAGIC-5288-j1Wqrn-intervention-85390-I-85789

title: GLP-1 RA Group in at-risk Adults with type 2 diabetes with moderate CV risk

status: Active

publisher: Computable Publishing LLC

contact: support@computablepublishing.com

description:

Glucagon-Like Peptide-1 (GLP-1) receptor agonists

\n

UseContexts

-CodeValue[x]
*Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication (Evidence Communication)ExposureGroup

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

\n

type: Person

membership: Enumerated

combinationMethod: All of

characteristic

code: Member of

value: Adults with type 2 diabetes and established CVD (but no CKD)

exclude: false

description:

inclusion in Adults with type 2 diabetes with moderate CV risk

\n

characteristic

code: Exposed to

value: Glucagon-Like Peptide-1 (GLP-1) receptor agonists

exclude: false

description:

received GLP-1 RA

\n
"^^rdf:XMLLiteral ] ] ; # fhir:extension ( [ fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/artifact-author"^^xsd:anyURI ; fhir:l ] ; fhir:value [ a fhir:ContactDetail ; fhir:name [ fhir:v "Computable Publishing®: MAGIC-to-FEvIR Converter" ] ] ] [ fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact"^^xsd:anyURI ; fhir:l ] ; fhir:value [ a fhir:RelatedArtifact ; fhir:type [ fhir:v "part-of" ] ; fhir:resourceReference [ fhir:type [ fhir:v "Composition"^^xsd:anyURI ; fhir:l fhir:Composition ] ; fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l ] ; fhir:value [ fhir:v "MAGIC-5288-j1Wqrn-conversion-report" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ; fhir:display [ fhir:v "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes" ] ] ] ] [ fhir:url [ fhir:v "http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as"^^xsd:anyURI ; fhir:l ] ; fhir:value [ a fhir:Markdown ; fhir:v "GLP-1 RA Group in at-risk Adults with type 2 diabetes with moderate CV risk [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236535. Revised 2026-01-29. Available at: https://fevir.net/resources/Group/236535. Computable resource at: https://fevir.net/resources/Group/236535#json." ] ] ) ; # fhir:url [ fhir:v "https://fevir.net/resources/Group/236535"^^xsd:anyURI ; fhir:l ] ; # fhir:identifier ( [ fhir:type [ fhir:coding ( [ fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/v2-0203"^^xsd:anyURI ; fhir:l ] ; fhir:code [ fhir:v "ACSN" ] ; fhir:display [ fhir:v "Accession ID" ] ] ) ; fhir:text [ fhir:v "FEvIR Object Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FOI"^^xsd:anyURI ; fhir:l ] ; fhir:value [ fhir:v "236535" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l ] ; fhir:value [ fhir:v "MAGIC-5288-j1Wqrn-intervention-group-MAGIC-5288-j1Wqrn-intervention-85390-I-85789" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ) ; # fhir:title [ fhir:v "GLP-1 RA Group in at-risk Adults with type 2 diabetes with moderate CV risk"] ; # fhir:status [ fhir:v "active"] ; # fhir:publisher [ fhir:v "Computable Publishing LLC"] ; # fhir:contact ( [ fhir:telecom ( [ fhir:system [ fhir:v "email" ] ; fhir:value [ fhir:v "support@computablepublishing.com" ] ] ) ] ) ; # fhir:description [ fhir:v "Glucagon-Like Peptide-1 (GLP-1) receptor agonists"] ; # fhir:useContext ( [ fhir:code [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l ] ; fhir:code [ fhir:v "evidence-communication" ] ; fhir:display [ fhir:v "Evidence Communication" ] ] ; fhir:value [ a fhir:CodeableConcept ; fhir:coding ( [ fhir:system [ fhir:v "https://fevir.net/resources/CodeSystem/179423"^^xsd:anyURI ; fhir:l ] ; fhir:code [ fhir:v "ExposureGroup" ] ; fhir:display [ fhir:v "ExposureGroup" ] ] ) ] ] ) ; # fhir:copyright [ fhir:v "https://creativecommons.org/licenses/by-nc-sa/4.0/"] ; # fhir:type [ fhir:v "person"] ; # fhir:membership [ fhir:v "enumerated"] ; # fhir:combinationMethod [ fhir:v "all-of"] ; # fhir:characteristic ( [ fhir:code [ fhir:text [ fhir:v "Member of" ] ] ; fhir:value [ a fhir:Reference ; fhir:l ; fhir:reference [ fhir:v "Group/236533" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l ] ; fhir:value [ fhir:v "MAGIC-5288-j1Wqrn-population-group-85390-85789" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ; fhir:display [ fhir:v "Adults with type 2 diabetes and established CVD (but no CKD)" ] ] ; fhir:exclude [ fhir:v false ] ; fhir:description [ fhir:v "inclusion in Adults with type 2 diabetes with moderate CV risk" ] ] [ fhir:code [ fhir:text [ fhir:v "Exposed to" ] ] ; fhir:value [ a fhir:Reference ; fhir:l ; fhir:reference [ fhir:v "Group/236532" ] ; fhir:type [ fhir:v "Group"^^xsd:anyURI ; fhir:l fhir:Group ] ; fhir:identifier [ fhir:type [ fhir:text [ fhir:v "FEvIR Linking Identifier" ] ] ; fhir:system [ fhir:v "https://fevir.net/FLI"^^xsd:anyURI ; fhir:l ] ; fhir:value [ fhir:v "MAGIC-5288-j1Wqrn-intervention-85390-I-85789" ] ; fhir:assigner [ fhir:display [ fhir:v "Computable Publishing LLC" ] ] ] ; fhir:display [ fhir:v "Glucagon-Like Peptide-1 (GLP-1) receptor agonists" ] ] ; fhir:exclude [ fhir:v false ] ; fhir:description [ fhir:v "received GLP-1 RA" ] ] ) . # a fhir:Uv . a fhir:Uv . # -------------------------------------------------------------------------------------